Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• HMG-CoA reductase inhibitors (statins) are proven to reduce cardiovascular morbidity and mortality.
• Initial benefits were attributed solely to lipid-lowering effects.
• Emerging evidence highlights pleiotropic actions on atherosclerotic lesions.

Purpose of the Study:

• To review the multifaceted effects of statins on atherosclerotic plaque development.
• To elucidate non-lipid-lowering mechanisms contributing to cardiovascular protection.

Main Methods:

• Literature review of studies investigating statin effects on atherosclerosis.
• Synthesis of findings on endothelial function, inflammation, smooth muscle cell behavior, and plaque stability.

Main Results:

• Statins improve endothelial dysfunction.
• They reduce leukocyte recruitment and inflammation within plaques.
• Statins modulate smooth muscle cell activation and proliferation.
• Evidence suggests statins impact plaque rupture and thrombosis.

Conclusions:

• Statins offer cardiovascular benefits beyond lipid reduction.
• Their pleiotropic effects on atherosclerotic processes are crucial for cardiovascular protection.
• Further research into these mechanisms can optimize therapeutic strategies.